NIH-funded research Fellowship grant

Understanding how X chromosome inactivation affects autoimmune disease in women

Official title: Defining the Role of Dynamic X Chromosome Inactivation in Age-Associated B Cells for Female-Biased Systemic Lupus Erythematosus

Funded at University of Pennsylvania · NIH-10914657 · Data updated 2026-11-12

This study is looking at how the X chromosome might play a role in lupus, a disease that mostly affects women, by checking how certain genes work in immune cells called B cells, to help us understand why more women get this condition.

More Female research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startJuly 1, 2023
Project endJune 30, 2026
Funding year2024
Award (this year)$36,512
NIH project number5F30AI174437-02
Project IDNIH-10914657 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women diagnosed with systemic lupus erythematosus, particularly those with varying numbers of X chromosomes.

Less likely to help

Patients who are male or do not have systemic lupus erythematosus may not benefit from this research.

What this research studies

This research investigates the role of X chromosome inactivation in the development of systemic lupus erythematosus (SLE), a condition that predominantly affects women. It focuses on how the expression of genes on the X chromosome may contribute to the disease, particularly in B cells, which are crucial for immune response. The study examines the dynamic nature of X chromosome inactivation in these cells and how it may be disrupted in individuals with SLE, potentially leading to increased disease activity. By exploring these mechanisms, the research aims to uncover new insights into the sex bias observed in autoimmune diseases.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for women suffering from systemic lupus erythematosus.

How similar studies have gone: While the specific approach of examining dynamic X chromosome inactivation in B cells is novel, related research has shown that understanding X-linked gene expression can provide insights into autoimmune diseases.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Lovell, Claudia Darnell — University of Pennsylvania
  • Study coordinator: Lovell, Claudia Darnell

Related research

Other NIH-funded projects on the same topics.

  • Immunostimulatory short non-coding RNAs and lupus

    A study in people with lupus looks at tiny RNA pieces that may spark inflammation, to understand if they drive disease activity.

    NIH research Thomas Jefferson University · Philadelphia, United States · NIH-11497703

  • Antiviral factors that limit HIV in people with SLE

    Researchers at Howard University are studying how immune factors in people with lupus may help limit HIV infection.

    NIH research Howard University · Washington, United States · NIH-11470887

  • Mechanistic clues about lupus from immune disorders

    This grant looks at why certain immune disorders in people with genetic immune problems lead to lupus-like symptoms, by studying patients and mouse models.

    NIH research Seattle Children's Hospital · Seattle, United States · NIH-11449228

  • Subjective thinking challenges in adults with lupus as they age

    This grant aims to understand how lupus-related cognitive problems affect adults, especially older adults, and tests a real-time method to track daily fluctuations in those symptoms.

    NIH research Hospital for Special Surgery · New York, UNITED STATES · NIH-11442899

  • Mitochondrial targets of antibodies in lupus (SLE)

    A Johns Hopkins-led study will identify which mitochondrial membrane proteins are targeted by autoantibodies in lupus patients to understand how these immune attacks fuel the disease.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11440181

  • Influenza, Hydroxychloroquine, and the Windows of Self-Peptide Presentation in Lupus

    A doctor-researcher is studying how flu infection and the lupus medication hydroxychloroquine change the way the immune system shows self-parts to trigger or prevent lupus flares in kids.

    NIH research Children's Hosp of Philadelphia · Philadelphia, United States · NIH-11438703

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.